Ledger.Open graph →
SEC Form D · filed July 12, 2023

ADvantage Therapeutics, Inc

Offering
$25.4M
Sold
$10.2M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
MIAMI, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

David B. Buchsbaum · Miami, FLExecWalter B. Schmidt · Miami, FLDirectorAgustin B. Fernandez Santana Iii · Miami, FLExec · DirectorJeffrey B. Madden · Miami, FLExec · DirectorFrank B. Mattner · Miami, FLDirectorDaniel Abrams · New York, NYExecKevin Kreisler · VIRGINIA CITY, NVDirectorJames B. O'Neill · Miami, FLDirectorNicholas D. Lewin · NATICK, MADirectorOmar J. Ishrak · NATICK, MAExecJames B. O'Neill · Miami, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗